Dr. Reddy's Laboratories Ltd. ADS (RDY) News Nov 18, 2014,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:03 AM

Dr. Reddy's Laboratories Ltd. ADS (RDY) News Nov 18, 2014, 10:01 a.m.
MarketWatch News on RDY
Top three Indian stocks to buy (and hold) 5:16 a.m. Oct. 17, 2014 - Henry To
India's drug makers move toward automation 7:26 p.m. June 5, 2014 - MarketWatch.com
The stock, currency, country and commodity for 2014 12:02 a.m. Jan. 7, 2014 - nigam arora
3 big reasons to invest in India 11:02 p.m. Sept. 2, 2013 - Nigam Arora
Dr Reddy's starts U.S. sales of baldness generic 5:18 a.m. Jan. 3, 2013 - MarketWatch.com
26 ways to profit from ‘Obamacare’ 6:01 a.m. Nov. 8, 2012 - The Trading Deck
Dr Reddy's bids 27.4 million euros for OctoPlus 11:49 p.m. Oct. 21, 2012 - MarketWatch.com
Dr Reddy's: US FDA lifts import ban on Mexico site 9:06 a.m. July 27, 2012 - MarketWatch.com
How to profit from the health-care ruling 12:55 p.m. June 28, 2012 - The Trading Deck
Dr Reddy's, Merck Serono to develop biotech drugs 2:45 a.m. June 6, 2012 - MarketWatch.com
Genpact to provide finance services to Dr Reddy's 3:00 a.m. May 22, 2012 - MarketWatch.com
India’s pharma, consumer stocks shine 11:18 a.m. May 18, 2012 - Nick Godt
Dr Reddy's: FDA to inspect Mexico plant in March 2:51 a.m. March 20, 2012 - MarketWatch.com
Dr Reddy's Laboratories net profit soars 88% 6:43 a.m. Feb. 3, 2012 - MarketWatch.com
Dr Reddy's 2nd-quarter net exceeds estimates 5:20 a.m. Oct. 25, 2011 - MarketWatch.com
Dr. Reddy's blood-cholesterol drug advances 9:16 a.m. Sept. 2, 2011 - MarketWatch.com
Sun Pharma looks past generics as challenges loom 4:48 a.m. July 15, 2011 - V. Phani Kumar
Dr Reddy's gets U.S. OK to sell generic Arixtra 12:01 a.m. July 13, 2011 - MarketWatch.com
FDA bans imports from Dr. Reddy Mexico plant 4:09 p.m. July 6, 2011 - MarketWatch.com
Seven demographic trends to buy now 12:01 a.m. March 10, 2011 - Jeff Reeves
Loading more headlines...
Advertisement
Other News on RDY
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
3 Drugs Stocks Pushing The Industry Higher 12:06 p.m. Nov. 7, 2014 - TheStreet.com
Today Dr Reddy Laboratories (RDY) Hits New Lifetime High 9:46 a.m. Nov. 7, 2014 - TheStreet.com
Dr. Reddy's cleared for generic Valcyte 7:34 a.m. Nov. 7, 2014 - Seeking Alpha
Dr. Reddy's Laboratories Ltd. (RDY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 7, 2014 - Zacks.com
Hottest Healthcare Stocks Now – RDY INCY MWIV PRGO 6:30 a.m. Nov. 7, 2014 - InvestorPlace.com
Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y - Analyst Blog 5:20 p.m. Oct. 30, 2014 - Zacks.com
Trade of the Day: Dr. Reddy’s Laboratories (RDY) 3:57 a.m. Oct. 30, 2014 - InvestorPlace.com
Dr. Reddy's Laboratories (RDY) Q2 2015 Results - Earnings Call Transcript 1:50 a.m. Oct. 30, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – BABY LUX PDLI ABBV 2:00 p.m. Oct. 22, 2014 - InvestorPlace.com
Sucampo Enters into Settlement Agreement for Amitiza - Analyst Blog 5:50 p.m. Oct. 13, 2014 - Zacks.com
Drugmaker M&A Goes On, With Or Without Tax Inversions 4:37 p.m. Oct. 10, 2014 - Investors Business Daily
Generics Firms Step Up Their Game In Branded Drugs 5:08 p.m. Oct. 6, 2014 - Investors Business Daily
Here’s What to Expect From Australian Biotechs 1:30 a.m. Oct. 6, 2014 - InvestorPlace.com
Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog 6:19 p.m. Sept. 25, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – ENDP RDY WX ACHN 1:30 p.m. Sept. 25, 2014 - InvestorPlace.com
New Lifetime High For Dr Reddy Laboratories (RDY) 9:47 a.m. Sept. 24, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – RDY SNN CBPO PTCT 8:15 a.m. Sept. 18, 2014 - InvestorPlace.com
Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock 9:45 a.m. Sept. 17, 2014 - TheStreet.com
Novartis heart failure drug candidate beats enalapril 12:05 p.m. Aug. 30, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on RDY
Dr. Reddy’s Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg 12:24 p.m. Oct. 28, 2014 - BusinessWire - BZX
Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014 4:38 a.m. Oct. 17, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP 2:27 a.m. Sept. 24, 2014 - BusinessWire - BZX
Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014 2:51 a.m. July 23, 2014 - BusinessWire - BZX
Corporate Updates, Certifications, and Product Launches - Analyst Notes on Analogic, Masimo, Dr. Reddy's, BioSpecifics and Bio-Rad 5:00 a.m. July 2, 2014 - PR Newswire - PRF
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F 2:28 a.m. June 27, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Duloxetine Delayed-Release Capsules USP 2:27 a.m. June 27, 2014 - BusinessWire - BZX
Dr. Reddy’s announces the Launch of Paricalcitol Capsules 9:22 a.m. June 25, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Research on Mylan, Sanofi, Impax Laboratories, and Dr. Reddy's Laboratories 6:30 a.m. June 3, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 4:10 a.m. May 29, 2014 - PR Newswire - PRF
Senior Level Changes at Dr. Reddy’s 2:59 a.m. May 14, 2014 - BusinessWire - BZX
Pre-market Equity Watch on the Health Care Sector -- Research on ArthroCare, HCA Holdings, Select Medical Holdings, and Dr Reddy's Laboratories 4:37 a.m. May 5, 2014 - PR Newswire - PRF
Dr. Reddy's to Release Q4 and Full Year FY14 Results on May 13, 2014 4:48 a.m. May 1, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Fenofibrate Capsules, USP 43 mg and 130 mg 1:53 a.m. April 23, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Eszopiclone Tablets C-IV 1:30 a.m. April 16, 2014 - BusinessWire - BZX
Product Launches, Acquisitions, Closed Offerings, Divestitures, and Financial Results - Analyst Notes on Dr. Reddy's, ICON, Endocyte, BioScrip, and DepoMed 7:00 a.m. April 7, 2014 - PR Newswire - PRF
Dr. Reddy’s Announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets 3:12 a.m. March 27, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Moxifloxacin Hydrochloride Tablets 2:22 a.m. March 5, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Sumatriptan Injection USP, Autoinjector System 12:44 a.m. Feb. 26, 2014 - BusinessWire - BZX
Dr. Reddy’s Q3 & 9 Months FY14 Financial Results 5:51 a.m. Feb. 11, 2014 - BusinessWire - BZX
Loading more headlines...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AHN Healthcare@Home Celebrates Fourth Top Workplace Win

Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...

Appy Pie Secures Patent for AI Driven App Building

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

Primrose Schools App: A Bold Step for Digital Literacy

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Elevest's Fund 70: High Hopes in Dallas Tower Deal

Aiming High in the Heart of Dallas Rolling the dice in downtown Dallas isn't for the faint-hearted, but Elevest Capital is strutting in with swagger. Their 70th fund acquisition—a 229-unit high-rise—is rocking the highest going-in cap rate the firm has ever snagged at 6.4%. Built in 2007 and lounging at a comfy 93% occupancy with zero concessions, this property sure...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Derek Pesta Shines: Forbes Top Wealth Advisors 2026

An Unwavering Dedication to Clients Every once in a while, the industry tips its hat to someone who truly knows what they're doing. Derek Pesta, head honcho at Pesta & Pesta Wealth Management, has landed on the 2026 Forbes Top Next-Gen Wealth Advisors Best-in-State list. It’s not just a pat on the back; it's a solid nod to the way he runs his game. You know it’s big...

J.P. Morgan, Thunes Partner for Global Payment Integration

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...